Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.

Florek K, Mutschler J, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC.

Vaccine. 2019 Nov 18. pii: S0264-410X(19)31440-9. doi: 10.1016/j.vaccine.2019.10.060. [Epub ahead of print]

PMID:
31753674
2.

Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.

Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, DeStefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, Belongia EA.

Pediatrics. 2019 Dec;144(6). pii: e20191808. doi: 10.1542/peds.2019-1808. Epub 2019 Nov 18.

PMID:
31740498
3.

Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.

Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Kim SS, Blanton L, Kniss K, Budd AP, Brammer L, Stark TJ, Barnes JR, Wentworth DE, Fry AM, Patel M.

J Infect Dis. 2019 Oct 30. pii: jiz543. doi: 10.1093/infdis/jiz543. [Epub ahead of print]

PMID:
31665373
4.

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.

Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, Weintraub ES, Belongia EA.

Vaccine. 2019 Oct 16;37(44):6673-6681. doi: 10.1016/j.vaccine.2019.09.035. Epub 2019 Sep 17.

5.

Incidence of Herpes Zoster Among Children: 2003-2014.

Weinmann S, Naleway AL, Koppolu P, Baxter R, Belongia EA, Hambidge SJ, Irving SA, Jackson ML, Klein NP, Lewin B, Liles E, Marin M, Smith N, Weintraub E, Chun C.

Pediatrics. 2019 Jul;144(1). pii: e20182917. doi: 10.1542/peds.2018-2917. Epub 2019 Jun 10.

PMID:
31182552
6.

Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents.

Hanson KE, McLean HQ, Belongia EA, Stokley S, McNeil MM, Gee J, VanWormer JJ.

Papillomavirus Res. 2019 Dec;8:100168. doi: 10.1016/j.pvr.2019.05.001. Epub 2019 May 25.

7.

Influenza Vaccine Effectiveness: Defining the H3N2 Problem.

Belongia EA, McLean HQ.

Clin Infect Dis. 2019 Oct 30;69(10):1817-1823. doi: 10.1093/cid/ciz411.

PMID:
31102401
8.

Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.

Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Foust A, Sessions W, Berman L, Garten RJ, Barnes JR, Wentworth DE, Fry AM, Patel MM, Flannery B.

MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):135-139. doi: 10.15585/mmwr.mm6806a2.

9.

Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.

McLean HQ, King JP, Talley P, Flannery B, Spencer S, Levine MZ, Friedrich TC, Belongia EA.

J Pediatric Infect Dis Soc. 2019 Feb 13. doi: 10.1093/jpids/piz001. [Epub ahead of print]

PMID:
30759228
10.

Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season.

Rolfes MA, Flannery B, Chung JR, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman RK, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, Kirley PD, Lynfield R, Monroe ML, Spencer M, Spina N, Talbot HK, Thomas A, Torres SM, Yousey-Hindes K, Singleton JA, Patel M, Reed C, Fry AM; US Influenza Vaccine Effectiveness (Flu VE) Network, the Influenza Hospitalization Surveillance Network, and the Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention .

Clin Infect Dis. 2019 Nov 13;69(11):1845-1853. doi: 10.1093/cid/ciz075.

PMID:
30715278
11.

Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.

McLean HQ, Caspard H, Griffin MR, Gaglani M, Peters TR, Poehling KA, Ambrose CS, Belongia EA.

JAMA Netw Open. 2018 Oct 5;1(6):e183742. doi: 10.1001/jamanetworkopen.2018.3742.

12.

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons.

Havers FP, Hicks LA, Chung JR, Gaglani M, Murthy K, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Flannery B, Fry AM.

JAMA Netw Open. 2018 Jun 1;1(2):e180243. doi: 10.1001/jamanetworkopen.2018.0243.

13.

Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old.

Belongia EA, King JP, Kieke BA, Pluta J, Al-Hilli A, Meece JK, Shinde V.

Open Forum Infect Dis. 2018 Nov 27;5(12):ofy316. doi: 10.1093/ofid/ofy316. eCollection 2018 Dec.

14.

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.

Shang M, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Fry AM, Flannery B.

Vaccine. 2018 Dec 18;36(52):8047-8053. doi: 10.1016/j.vaccine.2018.10.093. Epub 2018 Nov 9.

PMID:
30420119
15.

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011-12-2015-16.

Appiah GD, Chung JR, Flannery B, Havers FP, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Gaglani M, Murthy K, Jackson LA, Jackson ML, McLean HQ, Belongia EA, Fry AM.

Influenza Other Respir Viruses. 2019 Mar;13(2):133-137. doi: 10.1111/irv.12616. Epub 2018 Dec 19.

16.

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.

Havers FP, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, Fry AM, Flannery B.

Clin Infect Dis. 2019 May 2;68(10):1616-1622. doi: 10.1093/cid/ciy780.

17.

Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season.

Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM; US Flu VE Investigators .

Clin Infect Dis. 2019 May 17;68(11):1798-1806. doi: 10.1093/cid/ciy775.

18.

Validation of self-reported influenza vaccination in the current and prior season.

King JP, McLean HQ, Belongia EA.

Influenza Other Respir Viruses. 2018 Nov;12(6):808-813. doi: 10.1111/irv.12593. Epub 2018 Aug 14.

19.

Determinants of human papillomavirus vaccine attitudes: an interview of Wisconsin parents.

Barnes KL, VanWormer JJ, Stokley S, Vickers ER, McLean HQ, Belongia EA, Bendixsen CG.

BMC Public Health. 2018 Jun 15;18(1):746. doi: 10.1186/s12889-018-5635-y.

20.

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, Barnes JR, Spencer S, Fry AM.

MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185. doi: 10.15585/mmwr.mm6706a2.

21.

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B.

Vaccine. 2018 Feb 28;36(10):1272-1278. doi: 10.1016/j.vaccine.2018.01.045.

22.

Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.

King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA.

Vaccine. 2018 Feb 21;36(9):1214-1219. doi: 10.1016/j.vaccine.2018.01.016.

PMID:
29395525
23.

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.

Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R.

MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103-108. doi: 10.15585/mmwr.mm6703a5.

24.

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.

Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Griffin MR, Keipp Talbot H, Treanor JJ, Wentworth DE, Fry AM.

J Infect Dis. 2018 Jun 20;218(2):189-196. doi: 10.1093/infdis/jix634.

25.

Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.

Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.

Vaccine. 2018 Feb 1;36(6):818-826. doi: 10.1016/j.vaccine.2017.12.075. Epub 2018 Jan 6.

PMID:
29317117
26.

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.

Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B.

Vaccine. 2018 Jan 25;36(4):467-472. doi: 10.1016/j.vaccine.2017.12.014. Epub 2017 Dec 14.

27.

An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.

Florek NW, Campos LM, Braun KM, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC.

Vaccine. 2018 Jan 29;36(5):758-764. doi: 10.1016/j.vaccine.2017.12.024. Epub 2017 Dec 15.

28.

Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016.

Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson ML, Monto AS, Martin ET, Belongia EA, McLean HQ, Fry AM, Havers FP.

Clin Infect Dis. 2018 Mar 19;66(7):1035-1041. doi: 10.1093/cid/cix922.

29.

Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.

Carter TC, Hebbring SJ, Liu J, Mosley JD, Shaffer CM, Ivacic LC, Kopitzke S, Stefanski EL, Strenn R, Sundaram ME, Meece J, Brilliant MH, Ferdinands JM, Belongia EA.

J Med Virol. 2018 Mar;90(3):436-446. doi: 10.1002/jmv.24975. Epub 2017 Nov 11.

30.

Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.

Belongia EA.

J Infect Dis. 2017 Dec 19;216(12):1477-1480. doi: 10.1093/infdis/jix527. No abstract available.

PMID:
29029175
31.

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.

Poehling KA, Caspard H, Peters TR, Belongia EA, Congeni B, Gaglani M, Griffin MR, Irving SA, Kavathekar PK, McLean HQ, Naleway AL, Ryan K, Talbot HK, Ambrose CS.

Clin Infect Dis. 2018 Feb 10;66(5):665-672. doi: 10.1093/cid/cix869.

32.

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents.

VanWormer JJ, Bendixsen CG, Vickers ER, Stokley S, McNeil MM, Gee J, Belongia EA, McLean HQ.

BMC Public Health. 2017 Oct 2;17(1):766. doi: 10.1186/s12889-017-4787-5.

33.

Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations.

Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK.

Influenza Other Respir Viruses. 2018 Jan;12(1):122-131. doi: 10.1111/irv.12495. Epub 2018 Feb 15.

34.

Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA.

Vaccine. 2017 Sep 25;35(40):5314-5322. doi: 10.1016/j.vaccine.2017.06.069.

35.

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.

Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA.

Vaccine. 2017 Oct 13;35(43):5872-5877. doi: 10.1016/j.vaccine.2017.08.086. Epub 2017 Sep 6.

36.

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.

Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B.

N Engl J Med. 2017 Aug 10;377(6):534-543. doi: 10.1056/NEJMoa1700153.

37.

Influenza and Workplace Productivity Loss in Working Adults.

Van Wormer JJ, King JP, Gajewski A, McLean HQ, Belongia EA.

J Occup Environ Med. 2017 Dec;59(12):1135-1139. doi: 10.1097/JOM.0000000000001120.

PMID:
28759481
38.

The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.

Belongia EA, Karron RA, Reingold A, Walter EB, Bennett NM.

Vaccine. 2018 Jan 8;36(3):343-344. doi: 10.1016/j.vaccine.2017.06.017. Epub 2017 Jul 3. No abstract available.

PMID:
28684166
39.

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States.

Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Petrie JG, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Fry AM.

J Infect Dis. 2017 Jul 15;216(2):284-285. doi: 10.1093/infdis/jix286. No abstract available.

40.

Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.

Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G.

Expert Rev Vaccines. 2017 Jul;16(7):1-14. doi: 10.1080/14760584.2017.1334554. Epub 2017 Jun 9. Review. Erratum in: Expert Rev Vaccines. 2017 Aug;16(8):865-866.

PMID:
28562111
41.

Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.

McLean HQ, VanWormer JJ, Chow BDW, Birchmeier B, Vickers E, DeVries E, Meyer J, Moore J, McNeil MM, Stokley S, Gee J, Belongia EA.

J Adolesc Health. 2017 Aug;61(2):252-258. doi: 10.1016/j.jadohealth.2017.02.019. Epub 2017 Apr 24.

42.

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.

McLean HQ, Caspard H, Griffin MR, Poehling KA, Gaglani M, Belongia EA, Talbot HK, Peters TR, Murthy K, Ambrose CS.

Vaccine. 2017 May 9;35(20):2685-2693. doi: 10.1016/j.vaccine.2017.03.085. Epub 2017 Apr 10.

43.

Live attenuated influenza vaccine use and safety in children and adults with asthma.

Duffy J, Lewis M, Harrington T, Baxter R, Belongia EA, Jackson LA, Jacobsen SJ, Lee GM, Naleway AL, Nordin J, Daley MF; Vaccine Safety Datalink.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):439-444. doi: 10.1016/j.anai.2017.01.030.

44.

RE: "INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN".

Ferdinands JM, Foppa IM, Fry AM, Flannery BL, Belongia EA, Jackson ML.

Am J Epidemiol. 2017 Apr 1;185(7):613. doi: 10.1093/aje/kww227. No abstract available.

PMID:
28338844
45.

Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.

Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, Berman L, Spencer S, Fry AM.

MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):167-171. doi: 10.15585/mmwr.mm6606a3.

46.

Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.

Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, Belongia EA.

Clin Infect Dis. 2017 Mar 1;64(5):544-550. doi: 10.1093/cid/ciw816. Epub 2016 Dec 29.

PMID:
28039340
47.

School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.

McLean HQ, Peterson SH, King JP, Meece JK, Belongia EA.

Influenza Other Respir Viruses. 2017 May;11(3):220-229. doi: 10.1111/irv.12440. Epub 2017 Feb 15.

48.

Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.

Reber AJ, Kim JH, Coleman LA, Spencer SM, Chung JR, Chen J, Gargiullo P, Sundaram ME, Belongia EA, Shay DK, Katz JM, Sambhara S.

J Infect Dis. 2016 Nov 15;214(10):1477-1486. Epub 2016 Aug 28.

49.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B; US Flu VE Investigators; U.S. Flu VE Investigators.

Clin Infect Dis. 2016 Dec 15;63(12):1564-1573. Epub 2016 Oct 4.

50.

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients.

Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR.

BMC Infect Dis. 2016 Sep 22;16(1):503.

Supplemental Content

Loading ...
Support Center